PANNEXIN-1 MODULATORS AND METHODS OF TREATING DISORDERS IN WHICH PANNEXIN-1 IS IMPLICATED

PEPTIDYL NITRILE COMPOUND AND USE THEREOF

1H-CYCLOPENTA[B]BENZOFURAN DERIVATIVES FOR THE PREVENTION AND TREATMENT OF VIRUS DISEASES

1-(5-(2-CYANOPYRIDIN-4-YL)OXAZOLE-2-CARBONYL)-4-METHYLHEXAHYDROPYRROLO[3,4-B]PYR ROLE-5(1H)-CARBONITRILE ASUSP30 INHIBITOR FOR USE IN THE TREATMENT OF MITOCHONDRIAL DYSFUNCTION, CANCER AND FIBROSIS

WNT SIGNALING PATHWAY INHIBITORS FOR TREATMENTS OF DISEASE

QUINAZOLINE DERIVATIVE COMPOUND AND USE THEREOF

NOVEL COMPOUNDS

NOVEL ENANTIOMERS OF A SERIES OF ANTIVIRAL COMPOUNDS

IMIDAZOLE DERIVATIVES

INHIBITORS OF RIPK2 AND MEDICAL USES THEREOF

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

HIPK4 Degraders as Non-Hormonal Male Contraceptives

HETEROARYL COMPOUNDS AS MULTI-TARGET PROTEIN KINASE INHIBITORS

STAPHYLOCOCCUS AUREUS PBP4 INHIBITORS AND METHOD OF USE

MODULATORS OF BETA CATENIN AND USES THEREOF

COMPOUND FOR ORGANIC ELECTRONIC DEVICE, ORGANIC ELECTRONIC DEVICE USING THE SAME, AND ELECTRONIC DEVICE THEREOF

HETEROAROMATIC INDOLESULFONAMIDES

THIOPHENE BASED APYRASE INHIBITORS

METHOD FOR PREPARING DITHIOCYCLOPENTENONE DERIVATIVE AND APPLICATION THEREOF

SIRTUIN MODULATING COMPOUNDS, INCLUDING SIRTUIN ACTIVATING COMPOUNDS, AND APPLICATIONS THEREOF

2-AMINO IMIDAZOLE DERIVATIVES AS PRMT5 INHIBITORS

HETEROCYCLIC COMPOUNDS AND USES THEREOF

8-HYDROXYQUINOLINE COMPOUND AND USE THEREOF

NEGATIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2

BICYCLIC 1,4-DIAZEPANONES AND THERAPEUTIC USES THEREOF

Small molecule inhibitors of the ribosome biogenesis factor NVL2

PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS

COMPOUNDS FOR TARGETED PROTEIN DEGRADATION

BCL-XL/BCL-2 DEGRADERS AND USES THEREOF

PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE

COMPOSITIONS AND METHODS FOR TREATING CANCER

A NOVEL CRYSTALLINE FORM OF PRITELIVIR

SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF

ACSS2 INHIBITORS AND METHODS OF USE THEREOF

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

TPK AGONIST AND METHOD FOR USING SAME TO TREAT NEURODEGENERATIVE DISEASES

A NOVEL CRYSTALLINE FORM OF PRITELIVIR

N-(2-(4-CYANOTHIAZOLIDIN-3-YL)-2-OXOETHYL)-QUINOLINE-4-CARBOXAMIDES

HETEROCYCLE DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS

TNKS2 INHIBITORS

NOVEL DPP1 INHIBITORS AND USES THEREOF

INHIBITORS OF KIF18A AND USES THEREOF

PEROXIREDOXIN 3 INHIBITORS AND METHODS OF USE FOR TREATING CANCER

KCC2 POTENTIATORS AND USES THEREOF

Compounds

TOLFENPYRAD DERIVATIVES EXHIBIT POTENT FRANCISELLA-SPECIFIC ANTIBACTERIAL ACTIVITY WITHOUT TOXICITY TO MAMMALIAN CELLS IN VITRO

AZOLE PESTICIDAL COMPOUNDS

CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES AS DIPEPTIDYL PEPTIDASE 1 INHIBITORS

THIADIAZOLYL DERIVATIVES

SARS-COV-2 INHIBITORS FOR TREATING CORONAVIRUS INFECTIONS

SMALL MOLECULES AS KCNQ2/3 (KV7.2/3) CHANNEL ACTIVATORS AND THEIR MEDICAL USE THEREOF

PHENYLUREA DERIVATIVES AND THEIR PHARMACEUTICAL USES

KIT INHIBITORS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF

PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE

INHIBITORS OF MYC AND USES THEREOF

THIADIAZOLONE DERIVATIVES, COMPOSITIONS AND USES THEREOF

Generative AI-Assisted Identification of Novel PI3K-alpha Inhibitors

NOVEL ISOTHIAZOL-3-YL AND ISOXAZOL-3-YL SULFONAMIDE COMPOUNDS

COMPOUNDS AND METHODS FOR THE ENHANCED DEGRADATION OF TARGETED PROTEINS

N-(5-SUBSTITUTED-[(1,3,4-THIADIAZOLYL) OR (1,3-THIAZOLYL)](SUBSTITUTED)CARBOXAMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF PREPARING THE AMIDE COMPOUNDS AND OF THEIR USE

STIMULATOR OF INTERFERON GENES AGONISTS

BIARYL DERIVATIVES AND RELATED USES

ALKOXY HETEROARYL- CARBOXAMIDE OR THIOAMIDE COMPOUNDS

INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE

LINEAR DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOF

NOVEL INHIBITORS

BENZISOTHIAZOLE COMPOUND AND APPLICATION THEREOF, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF

TRIAZOLE DERIVATIVES AS MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR D

INHIBITOR COMPOUNDS

PYRIDINE CARBOXAMIDE COMPOUNDS FOR INHIBITING NAV1.8

SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS

Compounds, Compositions and Methods

TPK AGONIST AND METHOD FOR TREATING NEURODEGENERATIVE DISEASES USING SAME

FUSED BICYCLIC EGFR INHIBITORS AND METHODS OF USE THEREOF

COMPOUNDS INDUCING PRODUCTION OF PROTEINS BY IMMUNE CELLS

3-ALKYNYL CARBOXAMIDES AS AEP MODULATORS

NITROGEN-CONTAINING COMPOUND AND USE THEREOF

BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS

METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES

METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES

ISOXAZOLINE DERIVATIVE COMPOUND AND INSECTICIDAL COMPOSITION COMPRISING SAME

INDAZOLE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS

17-Beta-Hydroxysteroid Dehydrogenase Type 13 Inhibitors and Methods of Use Thereof

MASP-2 INHIBITORS AND METHODS OF USE

SOLID-STATE FORMS OF N-(2-(4-CYANOTHIAZOLIDIN-3-YL)-2-OXOETHYL)-6-MORPHOLINOQUINOLINE-4-CARBOXAMIDE

Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for their Preparation and Therapeutic Uses Thereof

MASP-2 INHIBITORS AND METHODS OF USE

IDENTIFICATION OF NOVEL BENZOTHIAZONES AS TAU-SH3 INTERACTION INHIBITORS FOR THE TREATMENT OF ALZHEIMER’S DISEASE

1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF

CSF-1R INHIBITORS AND USES THEREOF

FLAVIVIRUS INHIBITORS

BENZENE SULFONAMIDE THIAZOLE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCERS

DEGRADER COMPOUNDS OF QSOX1 mRNA

IMIDAZOPYRIDINE AND OXAZOLOPYRIDINE DERIVATIVES AND ANALOGS THEREOF, METHODS OF PREPARATION THEREOF, METHODS OF HIF-1/2A PATHWAY INHIBITION, AND INDUCTION OF FERROPTOSIS

NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS

AZAQUINOLINONE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF

NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS

INTRACELLULAR KINASE ASSOCIATED WITH RESISTANCE AGAINST ANTI-TUMOUR IMMUNE RESPONSES, AND USES THEREOF

GPR84 ANTAGONISTS AND USES THEREOF

SMALL MOLECULE MODULATORS OF GP130 SIGNALING PATHWAYS

IRAK DEGRADERS AND USES THEREOF

COMPOUNDS AND METHODS FOR INHIBITING FASCIN

DEUTERATED COMPOUNDS

CERTAIN PLADIENOLIDE COMPOUNDS AND METHODS OF USE

PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY

RILUZOLE PRODRUGS AND THEIR USE

EIF4E INHIBITORS AND USES THEREOF

PIPERAZINE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION

CHROMEN-2-ONE MODULATORS OF POLRMT

PI4-Kinase Inhibitors and Methods of Using the Same

INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

SUBSTITUTED THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS

HERBICIDAL DERIVATIVES

HSD17B13 INHIBITORS AND USES THEREOF

SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF

SIALIC ACID DERIVATIVES AND METHODS OF USING SAME

2-SUBSTITUTED THIAZOLE AND BENZOTHIAZOLE COMPOSITIONS AND METHODS AS DUX4 INHIBITORS

PTPN2 INHIBITORS

ALPHA 4 BETA 7 INTEGRIN MODULATORS AND USES THEREOF

PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS AS c-KIT KINASE INHIBITORS

3,4,6,7-TETRAHYDRO-2,7-NAPHTHYRIDINE-2(1H)-CARBOXAMIDE DERIVATIVES AS GPR65 INHIBITORS FOR THE TREATMENT OF CANCER AND AUTOIMMUNE DISEASES

BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF

Fused Heterobicyclic Antiviral Agents

A SYNTHESIS SCHEME AND PROCEDURES FOR PREPARING A SIK3 INHIBITOR AND INTERMEDIATES THEREOF

HETEROCYCLIC COMPOUNDS AND USES THEREOF

SELECTIVE LIGANDS FOR MODULATION OF GIRK CHANNELS

FORMULATIONS COMPRISING N-SUBSTITUTED-DIOXOCYCLOBUTENYLAMINO-3-HYDROXY-PICOLINAMIDE COMPOUNDS AND USES THEREOF

TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS

Inhibitors of Molluscum Contagiosum Infection and Methods Using the Same

HETEROCYCLIC DERIVATIVES AS MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS

REVERSIBLE LYSINE COVALENT MODIFIERS OF CDK2 AND USES THEREOF

INDOLE DERIVATIVE, METHOD FOR PREPARING SAME, AND USE THEREOF

GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO

OREXIN RECEPTOR AGONISTS

COMPOSITIONS FOR TREATING AND/OR PREVENTING CELL OR TISSUE NECROSIS SPECIFICALLY TARGETING CATHEPSIN C AND/OR CELA1 AND/OR CELA3A AND/OR STRUCTURALLY RELATED ENZYMES THERETO

4-AMINOPHENYL-THIAZOLE DERIVATIVES AND METHODS OF USE THEREOF

4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS

PYRAZOLE-SUBSTITUTED CYCLOPENTANOL ESTER DERIVATIVE AND USE THEREOF

HUMAN PLASMA KALLIKREIN INHIBITORS

METHODS OF TREATING NEUROLOGICAL, METABOLIC, AND OTHER DISORDERS USING ENANTIOPURE DEUTERIUM-ENRICHED PIOGLITAZONE

Compounds

DEUTERATED DERIVATIVES OF LANIFIBRANOR

NOVEL DRP-1 INHIBITORS AS THERAPEUTIC AGENTS

HUMAN PLASMA KALLIKREIN INHIBITORS

1,4-Substituted Piperidine Derivatives

BENZOTHIAZOLE-PHENYLSULFONYL-PIPERIDINE ANALOGS AS ACTIVATORS OF NACYLPHOSPHATIDYLETHANOLAMINE HYDROLYZING PHOSPHOLIPASE D

METHODS FOR TREATING CANCER

AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES

CRYSTALLINE FORM OF LANIFIBRANOR

A METHOD FOR THE PREPARATION OF INDOLE-3-CARBOXYLIC ACID DERIVATIVES

2,3-DIHYDROBENZO[B][1,4]DIOXIN-6-YL CONTAINING COMPOUNDS USEFUL AS IMMUNOMODULATORS

QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS

POTENT ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINS

CYCLOOLEFIN SUBSTITUTED HETEROAROMATIC COMPOUNDS AND THEIR USE

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR

SUBSTITUTED BENZAMIDES AS HERBICIDES

THIOBENZIMIDAZOLE DERIVATIVE PREPARATION METHOD AND NOVEL INTERMEDIATE THEREFOR

P2X3 INHIBITOR COMPOUND, SALT THEREOF, POLYMORPH THEREOF AND USE THEREOF

MULTICYCLIC COMPOUNDS

SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH

3,4-DIHYDROQUINOXALINE-2-CARBOXIMIDE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR PREVENTING OR TREATING CANCER DISEASE

THIOBENZIMIDAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND USE THEREOF

HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHOLOGICAL DISORDERS

ANTIMICROBIAL AGENTS

COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, HOLOGRAPHIC RECORDING MEDIUM, OPTICAL MATERIAL, AND OPTICAL COMPONENT

THIAZOLE DERIVATIVE COMPOUND AND USES THEREOF

METHOD FOR FORMING AMINOTHIAZOLE DERIVATIVES WITH SUPER-PARAMAGNETIC NANOPARTICLE CATALYST

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

Transcription Factor Brn2 Inhibitory Compounds for Use as Therapeutics

BCL-XL DEGRADERS AND USES THEREOF

COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES

NOVEL RAS INHIBITORS

2-OXO-DIHYDROQUINOLINE-3-CARBOXAMIDE DERIVATIVES AS GABA TYPE A RECEPTOR MODULATORS

THIADIAZOLE COMPOUND, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, INCLUDING SAME

METHOD OF FORMING BOND BY COUPLING REACTION

PROPIONIC ACID DERIVATIVE AND MEDICAL USE THEREOF

COMPOUNDS FOR TREATMENT OF CANCER

NON-AROMATIC CYCLIC-PYRIMIDINE ANALOGS AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

Telomerase Reverse Transcriptase (TERT) Expression Enhancing Compounds and Methods for Using the Same

RIP1 MODULATORS, PREPARATIONS, AND USES THEREOF

ELECTRON ACCEPTOR, AND REAGENT LAYER AND SENSOR EACH USING SAME

NEW ANTIVIRAL TRIAZOLE DERIVATIVES, THEIR SYNTHESIS AND THEIR USE FOR TREATMENT OF MAMMALIAN VIRAL INFECTIONS

INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF

PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS

METHOD FOR FORMING A SCHIFF BASE WITH CATALYTIC SUPER-PARAMAGNETIC IRON OXIDE NANOPARTICLES

PYRROLIDINE COMPOUNDS

MRGPRX2 MODULATORS AND RELATED METHODS OF TREATMENT

ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS

MODULATORS OF ACKR3 AND USES THEREOF

A METHOD FOR TREATING ROSAH SYNDROME

SUBSTITUTED 1,2,4-TRIAZOLES AND METHODS OF USE

MCL-1 INHIBITORS

1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF

PROTEIN DEGRADERS AND USES THEREOF

THIAZOLE COMPOUNDS AND METHODS OF USE THEREOF

MODULATORS OF THE INTEGRATED STRESS PATHWAY

CATHEPSIN K INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF

THIOSTREPTON-INSPIRED COMPOUNDS FOR TREATMENT OF CANCER AND PREPARATION THEREOF

RAD51 INHIBITORS

THIADIAZOLONE DERIVATIVES USEFUL AS AMPK ACTIVATOR

SMO MODULATOR COMPOUNDS

PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS

SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS

MASP-2 INHIBITORS AND METHODS OF USE

MYST Inhibitors

PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF

KAT6 Inhibitors

DIARYL COMPOUND AS TUBULIN/SRC DUAL TARGET INHIBITOR

SULFOXIMINE GLYCOSIDASE INHIBITORS

cGAS ANTAGONIST COMPOUNDS

PYRIDAZINE DERIVATIVES AND RELATED USES

BICYCLIC-SUBSTITUTED EPITHELIAL SODIUM CHANNEL BLOCKING COMPOUNDS

COMPOSITIONS AND METHODS FOR TREATING CANCER

PEPTIDYL NITRILE COMPOUND AND USE THEREOF

NOVEL KALIRIN INHIBITORS FOR REGULATION OF SYNAPTIC PLASTICITY AND NEUROPATHIC PAIN TREATMENT

SPIROCYCLIC CAV2.3 ANTAGONISTS

2-SUBSTITUTED THIAZOLE HSD17B13 INHIBITORS AND USES THEREOF

MERCAPTOPYRIMIDINE COMPOUNDS THAT INHIBIT NONHOMOLOGOUS END JOINING AND METHODS THEREOF

MEK INHIBITORS AND METHODS OF THEIR USE

COMPOSITIONS AND METHODS FOR TREATING CANCER

RIPK3 INHIBITORS AND METHODS OF USE

ENHANCERS OF PARTICULATE GUANYLYL CYCLASE RECEPTOR A

COMPOUNDS AND METHODS OF ACTIVATING LIPOPROTEIN LIPASE

NOVEL DRP-1 INHIBITORS AS THERAPEUTIC AGENTS

COMPOSITIONS AND METHODS FOR MAKING AND USING SMALL MOLECULES FOR TUBULIN-TARGETED THERAPY IN THE TREATMENT OF CANCERS AND RELATED CONDITIONS

SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS

SUBSTITUTED HETEROCYCLES AS HSET INHIBITORS

PYRAZOLE-SUBSTITUTED CYCLOPENTANOL ESTER DERIVATIVE AND USE THEREOF

PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF

4-SUBSTITUTED AMINOISOQUINOLINE DERIVATIVES

NSD2-TARGETED CHECMICAL DEGRADERTS AND COMPOSITIONS AND METHODS OF USE THEREOF

PYRIDAZINONES AS PARP7 INHIBITORS

Novel Aminobenzene Derivative Having Cancer Cell Growth Inhibitory Effect, and Preventive or Therapeutic Pharmaceutical Composition Containing Same as Active Ingredient

SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS

SOLID FORMS OF A BENZTHIAZOLE-PIPERAZINYL-OXAZOLE COMPOUND AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS OF USE TO TREAT 12-LIPOXYGENASE (12-LOX) MEDIATED DISEASES

BENZOTHIAZOLE, BENZOISOXAZOLE, AND BENZODIOXOLE ANALOGS AS RXFP1 RECEPTOR AGONISTS

NOVEL CANNABICHROMENIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION COMPRISING SAME FOR IMPROVING COGNITIVE FUNCTION

HETEROCYCLIC COMPOUNDS AS DYRK1A INHIBITORS

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

THIADIAZINE DERIVATIVES

Anti-inflammatory Compounds, Pharmaceutical Compositions, and Treatment Methods

Pharmaceutical Compounds and Compositions as C-Kit Kinase Inhibitors

CARDIAC SARCOMERE INHIBITORS

TLR MODULATOR AND USE THEREOF

MODULATORS OF MYOCYTE LIPID ACCUMULATION AND INSULIN RESISTANCE AND METHODS OF USE THEREOF

SMALL MOLECULE INHIBITORS OF PR3 AND HNE AND USES THEREOF

THERAPEUTIC COMPOUNDS AND METHODS

CRYSTALLINE FORMS OF A DEOXYCYTIDINE KINASE INHIBITOR AND USES THEREOF

N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof

PREPARATION OF INDOLONE-3YL-HYDRAZONO-SUBSTITUTED 1,3-THIAZOLIDINONE DERIVATIVES AND APPLICATION THEREOF

CHROMOBOX PROTEIN INHIBITORS AND USES THEREOF

QUINOLINE DERIVATIVES

EGFR INHIBITORS AND METHODS OF USE THEREOF

TETRAHYDROQUINAZOLINE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS

N-(5-SUBSTITUTED-[(1,3,4-THIADIAZOLYL) OR (THIAZOLYL)])(SUBSTITUTED)CARBOXAMIDE COMPOUNDS AND USE THEREOF FOR INHIBITING HUMAN POLYMERASE THETA

ENHANCERS OF PARTICULATE GUANYLYL CYCLASE RECEPTOR A

QUINAZOLINONE DIONE COMPOUNDS AND USES THEREOF

ARYL OR HETEROARYL DERIVATIVE, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF KINASE-RELATED DISEASES

SELECTIVE PEPTIDOMIMETIC MODULATORS OF CAV2.2 (N-TYPE) VOLTAGE-GATED CALCIUM CHANNELS AND USES THEREOF

PEROXIREDOXIN 3 INHIBITORS AND METHODS OF USE FOR TREATING CANCER

ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF

LONG-CHAIN COMPOUND THAT ACTS ON ACLY, PREPARATION METHOD THEREFOR AND USE THEREOF

HETEROCYCLIC COMPOUNDS AND USES THEREOF

FUSED BICYCLIC SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF

NOVEL PYRIDINE DERIVATIVE COMPOUND AS RON INHIBITOR

FLUORINE-CONTAINING PYRAZOLE COMPOUND AND PRODUCTION METHOD THEREFOR

CARBONIC ANHYDRASE IX-TARGETING RADIOACTIVE DIAGNOSTIC AND THERAPEUTIC MEDICAMENT AND METHOD FOR PREPARING SAME

HMOX1 INDUCERS

ORGANIC COMPOUNDS

COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER

Methods for treating cancer

SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

Substituted Quinoxalines

QUINACRINE AND DERIVATIVES THEREOF FOR TREATMENT OF VIRAL INFECTIONS

ISOQUINOLINONES AND QUINOLINONES AS MODULATORS OF POLRMT

PHENYL CORE COMPOUNDS AS MGLU5 NEGATIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING THE SAME

Compounds for Treating Cannabinoid Toxicity and Acute Cannabinoid Overdose

COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE

SMARCA DEGRADERS AND USES THEREOF

INHIBITORS OF TRANSGLUTAMINASES

BIFUNCTIONAL DEGRADERS COMPRISING A TEAD BINDER

NOVEL INHIBITOR OF HYPE-MEDIATED AMPYLATION

PRMT5 INHIBITOR AND THE USE THEREOF

MODULATORS OF PrPC AND USES THEREOF

THIADIAZOLEAMIDE DERIVATIVES AND THEIR APPLICATIONS

INHIBITORS OF ALPHA-HEMOLYSIN OF STAPHYLOCOCCUS AUREUS

NAMPT INHIBITORS AND USES THEREOF

INHIBITORS OF TRANSGLUTAMINASES

N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors

CERTAIN PLADIENOLIDE COMPOUNDS AND METHODS OF USE

SUBSTITUTED TETRAHYDROFURAN-2-CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS

JAK2 INHIBITORS AND METHODS OF USE THEREOF

ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS

Fused Heterobicyclic Antiviral Agents

BICYCLIC 1,4-DIAZEPANONES AND THERAPEUTIC USES THEREOF

RAD51 INHIBITORS

SMALL MOLECULE UREA DERIVATIVES AS STING ANTAGONISTS

HETEROCYCLIC COMPOUNDS AS SEROTONIN (5-HT) 5-HT2A AND 5-HT2C RECEPTOR POSITIVE ALLOSTERIC MODULATORS